Share on

Global Transfection Reagents and Equipment Market Size, Share, Trends, COVID-19 Impact & Growth Analysis Report – Segmented By Product, Method, Application, End User & Region - Industry Forecasts (2022 to 2027)

Published: January, 2022
ID: 3086
Pages: 175
Formats: report pdf report excel report power bi report ppt

Global Transfection Reagents and Equipment Market Size (2022 to 2027)

As per our report, the global transfection reagents and equipment market size was worth USD 888.73 million in 2022. It is expected to grow at a CAGR of 7.5 % to reach USD 1275.89 billion by 2027.

MARKET DRIVERS:

The growth of the global transfection reagents and equipment is being led by the rising prevalence of infectious diseases, the use of biopharmaceuticals in protein processing, and the rising obesity rate.

Increased focus on the advancement of protein therapeutics, government initiatives to promote health care, and the rising prevalence of diseases such as cancer and cardiovascular diseases drive the transfection reagents and equipment market. Advances in cell research, target validation, drug development, and technical advancements, including synthetic genes, which are in high demand, are expected to lead to the market's growth. The development of Biosimilars is highly reliant on a mixture of genomics, proteomics, and cytological analysis, necessitating extensive use of transfection procedures.

Increasing the adoption of reagents by the healthcare industry, research laboratories for future growth can drive the transfection reagents & equipment market. Incidence of the cancer diagnosis, developed infrastructure of healthcare & pharmaceutical industry and emerging economies are also raising demand for the market growth.

During the forecast period, increasing demand for synthetic genes is expected to open new opportunities for the global transfection reagents and equipment market. Protein mass production is expected to drive the industry forward in the near future. Furthermore, the growth of large-scale transfections and developing markets such as India and China are expected to provide opportunities for market players.

MARKET RESTRAINTS:

Extraction of DNA & RNA by transfection reagents & equipment is very costly and can hamper the global transfection reagents and equipment market growth.

The dearth of skilled professionals in diagnostic centers may also negatively impact the growth rate. The possibility of inserting genetic material into a cell, the high cost of transfection reagents and supplies, the selective efficacy of transfection reagents, the cytotoxic effects associated with the procedure are likely to restrict market development. The demand for transfection reagents and devices is likely to be hampered by the selective effectiveness of transfection reagents and a ban on homebrew reagents being sold as consumer kits.

COVID-19 Impact on the global transfection reagents and equipment market:

Covid-19 (SARS CoV-2) has spread around the globe and is now a deadly pandemic. While most of those infected survive, the virus's side effects can be severe and long-lasting. COVID-19 disease continued to spread around the world, infecting millions of people worldwide, prompting large governments around the world to impose foot bans and work stoppage orders. Transfection is the method of introducing genetic material such as DNA or RNA into eukaryotic cells to enable the cell's own machinery to produce or express proteins. This procedure utilizes transfection reagents and equipment, with the reagents containing the genetic material and the equipment acting as a medium for the genetic material. As more covid-19 cases increase day by day, more markets are focusing on providing equipment and products related to patient recovery. The transfection reagents and equipment market is forecasted to have a negative impact during this pandemic.

REPORT COVERAGE:

REPORT METRIC

DETAILS

Market Size Available

2021 to 2027

Base Year

2021

Forecast Period

2022 to 2027

Segments Analysed

By Product, Type, Route of Administration, and Region

Various Analyses Covered

Global, Regional & Country Level Analysis, Segment-Level Analysis, Drivers, Restraints, Opportunities, Challenges, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities

Regions Analysed

North America, Europe, Asia Pacific, Latin America, Middle East, and Africa

 

This research report on the global transfection reagents and equipment market has been segmented based on the product, route of administration, and region.

Transfection Reagents and Equipment Market - By Product:

  • Reagents
  • Instruments

Based on the product type, the reagents category is projected to account for the biggest market share in 2019. Although, the instruments market is probably growing at the highest CAGR during the aforementioned forecast period. Throughout the projected period, the segment is predicted to retain its domination. This is due to a vast range of new product releases from major players aiming to expand their reagents portfolio.

Transfection Reagents and Equipment Market - By Method:

  • Biochemical
  • Calcium Phosphate
  • Physical
  • Viral

Based on the method, the biochemical category is projected to command the largest market share in 2019. In contrast, the viral category is estimated to grow at the highest CAGR during the aforementioned forecast period.

Transfection Reagents and Equipment Market - By Application

  • Biomedical Research
  • Protein Production
  • Therapeutic Delivery

Based on the application, the biomedical research segment is expected to take the lead in the global transfection reagents and equipment market during the forecast period.

Transfection Reagents and Equipment Market - By End User

  • Academic & Research Institutes
  • Pharmaceutical & Biotechnology Companies         

Based on end-user, the academic & research institutes category is likely to command the largest market share. Although, the pharmaceutical & biotechnologies category is estimated to grow at the highest CAGR during the aforementioned forecast period.

Transfection Reagents and Equipment Market - By Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • The Middle East and Africa

Presently, North America accounts for the largest market share, closely followed by Europe, while Asia Pacific has the highest CAGR. Due to increased bio-based drug research, increased demand for protein therapeutics, and increased investment in biologics production in the region, North America dominates the transfection reagents and equipment industry. This is due to the presence of well-known suppliers, and substantial funds to support cancer therapeutics, precision medicine, and advanced cytological studies R&D. The region's increased growth opportunity will help key market players increase their sales in the transfection reagents and equipment market in the United States.

Because of the growing trend of targeted drug delivery, nanomedicine in diagnostics, clinical trials, and drug development studies, Europe was the second-largest market for transfection reagents and equipment.

Asia-Pacific has also considered a developing market in its initial stages in the transfection reagents and equipment market. Advances in transfection technology, an increase in demand for protein therapeutics, the growth of healthcare infrastructure in emerging markets such as India and China, and increased demand from applied markets are all factors to consider.

KEY MARKET PARTICIPANTS:

Major companies in the global transfection reagents and equipment market profiled in the report are Thermo Fisher Scientific Inc. (U.S.), Promega Corporation (U.S.), Hoffmann-La Roche Ltd. (Switzerland), and QIAGEN N.V. (Netherlands), Polyplus-transfection SA (France), Bio-Rad Laboratories (U.S.), Lonza Group (Switzerland), Sigma-Aldrich Corporation (U.S.), Mirus Bio LLC (U.S.), and MaxCyte Inc. (U.S.).

These companies hold a leading position in the transfection reagent and equipment market because of their well-established presence in the fields of genomics, spanning fifty countries, heavy R&D investments, and strong sales as well as distribution force.

RECENT MARKET DEVELOPMENTS:

  • On October 10, 2019, Nuvec pharma developed the DNA & RNA Transfection technology using silica nanoparticles with the irregular surface. It can trap, protect the nucleic acid during cell formation. The nucleic acid transfection technology responds to the T-cells; this is necessary to kill cancer cells or viruses.  

Please wait. . . . Your request is being processed

Related Reports

Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2500

Didn’t find what you’re looking for?
TALK TO OUR ANALYST TEAM

Need something within your budget?
NO WORRIES! WE GOT YOU COVERED!

REACH OUT TO US

Call us on: +1 888 702 9696 (U.S Toll Free)

Write to us: sales@marketdataforecast.com

Click for Request Sample